L&H files for Chapter 11 bankruptcy

Article

Faced with plummeting revenue, mounting shareholder lawsuits, and investigations by the U.S. Securities and Exchange Commission (SCAN, 10/11/00) and the Nasdaq stock exchange, Belgian voice recognition technology provider Lernout & Hauspie has filed for

Faced with plummeting revenue, mounting shareholder lawsuits, and investigations by the U.S. Securities and Exchange Commission (SCAN, 10/11/00) and the Nasdaq stock exchange, Belgian voice recognition technology provider Lernout & Hauspie has filed for Chapter 11 bankruptcy protection.

L&H has partnerships and strategic alliances with most PACS and RIS vendors. The firm says it will continue operating as it seeks to reorganize its debt.

The SEC and Nasdaq began investigating L&H earlier this year in relation to questionable accounting practices. The SEC is focusing on L&H's business dealings in Korea and Singapore. Revenue in those areas appeared to be strong last quarter but could turn out to be part of a complicated bundle of investments connected to the FLV Fund, a Belgian venture capital company linked to L&H founders Jo Lernout and Pol Hauspie. n

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.